Royalty Pharma (RPRX) Dividends Paid - Common (2019 - 2026)

Royalty Pharma has reported Dividends Paid - Common for 8 years, with the latest figure at $39.9 million in Q1 2026.

• Quarterly Dividends Paid - Common fell 25.92% year-over-year to $39.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.5 million (up 4.45% YoY) and the FY2025 annual result came in at $167.5 million, up 33.81% from the prior year.
• Dividends Paid - Common fell to $39.9 million in Q1 2026 per RPRX's latest filing, from $40.8 million in the prior quarter.
• Over five years, Dividends Paid - Common peaked at $53.8 million in Q1 2025 and troughed at $24.5 million in Q4 2023.
• A 5-year average of $35.1 million and a median of $33.4 million in 2023 frame the typical range for Dividends Paid - Common.
• The widest YoY moves for Dividends Paid - Common: up 114.4% in 2022, down 72.55% in 2022.
• Over 5 years, Dividends Paid - Common stood at $33.2 million in 2022, then retreated by 26.13% to $24.5 million in 2023, then rose by 28.42% to $31.4 million in 2024, then gained by 29.6% to $40.8 million in 2025, then slipped by 2.15% to $39.9 million in 2026.
• According to Business Quant data, Dividends Paid - Common over the past three periods registered $39.9 million, $40.8 million, and $34.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.